TORONTO, ON / ACCESSWIRE / February 7, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has been chosen as one of a small and select group of candidates, to be a founding participant in the PariSanté Health Tech Campus, located in Paris, France. The PariSanté Campus is described as the heart of e-health research and innovation in France. Its ambition is to mobilize and multiply the efforts of collective health-tech intelligence by bringing together thousands of individuals representing the finest researchers, public operators, universities, start-ups, and manufacturers in a unique and rich ecosystem conducive to innovation.
“Being chosen to participate in this highly specialized technology campus affords Tech2Heal the opportunity to leverage off of the expertise of some of the best-known health-tech companies that France has to offer,” said Tim Daniels, Chairman of AI/ML Innovations. “As well, Tech2heal’s selection reaffirms that they are being recognized as a leader amongst the emerging digital mental healthcare providers in France.”
The Campus is anchored by a core group of entities which includes Inserm (France’s National Institute of Health and Medical Research), Health Data Hub (a public company facilitating secure data access), Paris Sciences et Lettres University (a public research university), The Inria Paris Research Centre (National Institute for Research in Digital Science and Technology), and Agence du Numerique en Sante (Digital Health Agency of France). https://parisantecampus.fr/
